Futura’s Revolutionary ED Treatment One Step Closer To US And EU OTC Approval
Executive Summary
US and EU OTC approval for Futura's drug-free erectile dysfunction treatment MED3000 edges closer, following the company's submission of its EU dossier and a second pre-submission meeting with the FDA.
You may also be interested in...
Pfizer's Upjohn Breaking The Silence Around ED With New Viagra Connect Campaign In UK
Pfizer is investing roughly $10m in Viagra Connect in the UK to help raise awareness of erectile problems among the country's male population.
Watch Out Viagra! UK’s Futura Set To Shake Up Global ED Market With MED3000
HBW Insight talks exclusively to Futura Medical about its new erectile dysfunction product MED3000, which it says could take the global OTC market by storm.
Perrigo To Launch UK Private-Label Viagra Connect Competitor
Perrigo is launching in the UK an OTC sildenafil generic to compete with Pfizer's erectile dysfunction drug Viagra Connect.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: